DCF Advisers’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.76M | Sell |
462,987
-20,013
| -4% | -$163K | 1.74% | 19 |
|
|
2025
Q1 | $3.4M | Sell |
483,000
-56,989
| -11% | -$401K | 1.63% | 19 |
|
|
2024
Q4 | $4.01M | Buy |
539,989
+251,511
| +87% | +$1.87M | 1.94% | 17 |
|
|
2024
Q3 | $1.42M | Sell |
288,478
-2,206
| -0.8% | -$10.9K | 0.57% | 37 |
|
|
2024
Q2 | $1.49M | Buy |
290,684
+6,000
| +2% | +$30.8K | 0.77% | 37 |
|
|
2024
Q1 | $1.51M | Buy |
284,684
+25,000
| +10% | +$133K | 0.74% | 28 |
|
|
2023
Q4 | $1.61M | Buy |
259,684
+138,930
| +115% | +$860K | 0.87% | 27 |
|
|
2023
Q3 | $911K | Buy |
120,754
+33,254
| +38% | +$251K | 0.5% | 38 |
|
|
2023
Q2 | $846K | Buy |
+87,500
| New | +$846K | 0.45% | 38 |
|